ResearcherChongqing Medical UniversityNo recent work listed

Liang Liu

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-4716-7540; OpenAlex author ID A5100322363.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper

Papers 1

Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of Pancreatic Cancer. First author DOI 10.1021/acsami.3c01967 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ning Jiang · 1 shared paper, 2023
- Paper Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Ph… DOI 10.1021/acsami.3c01967 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.